← FDA Drug Approvals (Drugs@FDA)

EPHEDRINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-04-21

Drug application

FDA Application #

ANDA215825

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPHEDRINE SULFATE

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Xiromed, LLC

First approval

2022-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown